The global Myasthenia Gravis Disease market is projected to grow from US$ 1067.7 million in 2023 to US$ 1751.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period.

Myasthenia Gravis Disease Market

Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be sudden. Those affected often have a large thymus gland or develop a thymoma.

Market Analysis and Insights: Global Myasthenia Gravis Disease Market

Myasthenia gravis is generally treated with medications known as acetylcholinesterase inhibitors such as neostigmineand pyridostigmine. Immunosuppressants, such as prednisone or azathioprine, may also be used. The surgical removal of the thymus gland may improve symptoms in certain cases. Plasmapheresis and high dose intravenous immunoglobulin may be used during sudden flares of the condition. If the breathing muscles become significantly weak, mechanical ventilation may be required.

Report Includes

This report presents an overview of global market for Myasthenia Gravis Disease market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Myasthenia Gravis Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Myasthenia Gravis Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Myasthenia Gravis Disease revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Myasthenia Gravis Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Myasthenia Gravis Disease revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bausch Health, Sun Pharmaceuticals Industries, Novartis Pharmaceuticals, Teva Pharmaceutical Industries, Cipla, Roche, Apotex Corporation, Pfizer and Bristol-Myers And Company, etc.

Scope of Myasthenia Gravis Disease Market Report

Report Metric	Details
Report Name	Myasthenia Gravis Disease Market
Accounted market size in 2023	US$ 1067.7 million
Forecasted market size in 2029	US$ 1751.5 million
CAGR	8.6
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Medication Surgery Hematopoietic Stem Cell Transplantation (HSCT) Other
Segment by Application	Hospitals Clinics Academic Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bausch Health, Sun Pharmaceuticals Industries, Novartis Pharmaceuticals, Teva Pharmaceutical Industries, Cipla, Roche, Apotex Corporation, Pfizer, Bristol-Myers And Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Myasthenia Gravis Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Myasthenia Gravis Disease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Myasthenia Gravis Disease Market growing?

Ans: The Myasthenia Gravis Disease Market witnessing a CAGR of 8.6 during the forecast period 2023-2029.

What is the Myasthenia Gravis Disease Market size in 2029?

Ans: The global Myasthenia Gravis Disease market is projected to grow from US$ 1067.7 million in 2023 to US$ 1751.5 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period.

Who are the main players in the Myasthenia Gravis Disease Market report?

Ans: The main players in the Myasthenia Gravis Disease Market are Bausch Health, Sun Pharmaceuticals Industries, Novartis Pharmaceuticals, Teva Pharmaceutical Industries, Cipla, Roche, Apotex Corporation, Pfizer, Bristol-Myers And Company

What are the Application segmentation covered in the Myasthenia Gravis Disease Market report?

Ans: The Applications covered in the Myasthenia Gravis Disease Market report are Hospitals, Clinics, Academic Research Institutes

What are the Type segmentation covered in the Myasthenia Gravis Disease Market report?

Ans: The Types covered in the Myasthenia Gravis Disease Market report are Medication, Surgery, Hematopoietic Stem Cell Transplantation (HSCT), Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Myasthenia Gravis Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Medication

1.2.3 Surgery

1.2.4 Hematopoietic Stem Cell Transplantation (HSCT)

1.2.5 Other

1.3 Market by Application

1.3.1 Global Myasthenia Gravis Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Academic Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Myasthenia Gravis Disease Market Perspective (2018-2029)

2.2 Global Myasthenia Gravis Disease Growth Trends by Region

2.2.1 Myasthenia Gravis Disease Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Myasthenia Gravis Disease Historic Market Size by Region (2018-2023)

2.2.3 Myasthenia Gravis Disease Forecasted Market Size by Region (2024-2029)

2.3 Myasthenia Gravis Disease Market Dynamics

2.3.1 Myasthenia Gravis Disease Industry Trends

2.3.2 Myasthenia Gravis Disease Market Drivers

2.3.3 Myasthenia Gravis Disease Market Challenges

2.3.4 Myasthenia Gravis Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Myasthenia Gravis Disease by Players

3.1.1 Global Myasthenia Gravis Disease Revenue by Players (2018-2023)

3.1.2 Global Myasthenia Gravis Disease Revenue Market Share by Players (2018-2023)

3.2 Global Myasthenia Gravis Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Myasthenia Gravis Disease, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Myasthenia Gravis Disease Market Concentration Ratio

3.4.1 Global Myasthenia Gravis Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Disease Revenue in 2022

3.5 Global Key Players of Myasthenia Gravis Disease Head office and Area Served

3.6 Global Key Players of Myasthenia Gravis Disease, Product and Application

3.7 Global Key Players of Myasthenia Gravis Disease, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Myasthenia Gravis Disease Breakdown Data by Type

4.1 Global Myasthenia Gravis Disease Historic Market Size by Type (2018-2023)

4.2 Global Myasthenia Gravis Disease Forecasted Market Size by Type (2024-2029)

5 Myasthenia Gravis Disease Breakdown Data by Application

5.1 Global Myasthenia Gravis Disease Historic Market Size by Application (2018-2023)

5.2 Global Myasthenia Gravis Disease Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Myasthenia Gravis Disease Market Size (2018-2029)

6.2 North America Myasthenia Gravis Disease Market Size by Type

6.2.1 North America Myasthenia Gravis Disease Market Size by Type (2018-2023)

6.2.2 North America Myasthenia Gravis Disease Market Size by Type (2024-2029)

6.2.3 North America Myasthenia Gravis Disease Market Share by Type (2018-2029)

6.3 North America Myasthenia Gravis Disease Market Size by Application

6.3.1 North America Myasthenia Gravis Disease Market Size by Application (2018-2023)

6.3.2 North America Myasthenia Gravis Disease Market Size by Application (2024-2029)

6.3.3 North America Myasthenia Gravis Disease Market Share by Application (2018-2029)

6.4 North America Myasthenia Gravis Disease Market Size by Country

6.4.1 North America Myasthenia Gravis Disease Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Myasthenia Gravis Disease Market Size by Country (2018-2023)

6.4.3 North America Myasthenia Gravis Disease Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Myasthenia Gravis Disease Market Size (2018-2029)

7.2 Europe Myasthenia Gravis Disease Market Size by Type

7.2.1 Europe Myasthenia Gravis Disease Market Size by Type (2018-2023)

7.2.2 Europe Myasthenia Gravis Disease Market Size by Type (2024-2029)

7.2.3 Europe Myasthenia Gravis Disease Market Share by Type (2018-2029)

7.3 Europe Myasthenia Gravis Disease Market Size by Application

7.3.1 Europe Myasthenia Gravis Disease Market Size by Application (2018-2023)

7.3.2 Europe Myasthenia Gravis Disease Market Size by Application (2024-2029)

7.3.3 Europe Myasthenia Gravis Disease Market Share by Application (2018-2029)

7.4 Europe Myasthenia Gravis Disease Market Size by Country

7.4.1 Europe Myasthenia Gravis Disease Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Myasthenia Gravis Disease Market Size by Country (2018-2023)

7.4.3 Europe Myasthenia Gravis Disease Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Myasthenia Gravis Disease Market Size (2018-2029)

8.2 China Myasthenia Gravis Disease Market Size by Type

8.2.1 China Myasthenia Gravis Disease Market Size by Type (2018-2023)

8.2.2 China Myasthenia Gravis Disease Market Size by Type (2024-2029)

8.2.3 China Myasthenia Gravis Disease Market Share by Type (2018-2029)

8.3 China Myasthenia Gravis Disease Market Size by Application

8.3.1 China Myasthenia Gravis Disease Market Size by Application (2018-2023)

8.3.2 China Myasthenia Gravis Disease Market Size by Application (2024-2029)

8.3.3 China Myasthenia Gravis Disease Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Myasthenia Gravis Disease Market Size (2018-2029)

9.2 Asia Myasthenia Gravis Disease Market Size by Type

9.2.1 Asia Myasthenia Gravis Disease Market Size by Type (2018-2023)

9.2.2 Asia Myasthenia Gravis Disease Market Size by Type (2024-2029)

9.2.3 Asia Myasthenia Gravis Disease Market Share by Type (2018-2029)

9.3 Asia Myasthenia Gravis Disease Market Size by Application

9.3.1 Asia Myasthenia Gravis Disease Market Size by Application (2018-2023)

9.3.2 Asia Myasthenia Gravis Disease Market Size by Application (2024-2029)

9.3.3 Asia Myasthenia Gravis Disease Market Share by Application (2018-2029)

9.4 Asia Myasthenia Gravis Disease Market Size by Region

9.4.1 Asia Myasthenia Gravis Disease Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Myasthenia Gravis Disease Market Size by Region (2018-2023)

9.4.3 Asia Myasthenia Gravis Disease Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Type

10.2.1 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Application

10.3.1 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Country

10.4.1 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bausch Health

11.1.1 Bausch Health Company Details

11.1.2 Bausch Health Business Overview

11.1.3 Bausch Health Myasthenia Gravis Disease Introduction

11.1.4 Bausch Health Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.1.5 Bausch Health Recent Developments

11.2 Sun Pharmaceuticals Industries

11.2.1 Sun Pharmaceuticals Industries Company Details

11.2.2 Sun Pharmaceuticals Industries Business Overview

11.2.3 Sun Pharmaceuticals Industries Myasthenia Gravis Disease Introduction

11.2.4 Sun Pharmaceuticals Industries Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.2.5 Sun Pharmaceuticals Industries Recent Developments

11.3 Novartis Pharmaceuticals

11.3.1 Novartis Pharmaceuticals Company Details

11.3.2 Novartis Pharmaceuticals Business Overview

11.3.3 Novartis Pharmaceuticals Myasthenia Gravis Disease Introduction

11.3.4 Novartis Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.3.5 Novartis Pharmaceuticals Recent Developments

11.4 Teva Pharmaceutical Industries

11.4.1 Teva Pharmaceutical Industries Company Details

11.4.2 Teva Pharmaceutical Industries Business Overview

11.4.3 Teva Pharmaceutical Industries Myasthenia Gravis Disease Introduction

11.4.4 Teva Pharmaceutical Industries Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.4.5 Teva Pharmaceutical Industries Recent Developments

11.5 Cipla

11.5.1 Cipla Company Details

11.5.2 Cipla Business Overview

11.5.3 Cipla Myasthenia Gravis Disease Introduction

11.5.4 Cipla Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.5.5 Cipla Recent Developments

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Myasthenia Gravis Disease Introduction

11.6.4 Roche Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.6.5 Roche Recent Developments

11.7 Apotex Corporation

11.7.1 Apotex Corporation Company Details

11.7.2 Apotex Corporation Business Overview

11.7.3 Apotex Corporation Myasthenia Gravis Disease Introduction

11.7.4 Apotex Corporation Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.7.5 Apotex Corporation Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Myasthenia Gravis Disease Introduction

11.8.4 Pfizer Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.8.5 Pfizer Recent Developments

11.9 Bristol-Myers And Company

11.9.1 Bristol-Myers And Company Company Details

11.9.2 Bristol-Myers And Company Business Overview

11.9.3 Bristol-Myers And Company Myasthenia Gravis Disease Introduction

11.9.4 Bristol-Myers And Company Revenue in Myasthenia Gravis Disease Business (2018-2023)

11.9.5 Bristol-Myers And Company Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bausch Health

Sun Pharmaceuticals Industries

Novartis Pharmaceuticals

Teva Pharmaceutical Industries

Bristol-Myers And Company

List of Tables

Table 1. Global Myasthenia Gravis Disease Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Medication

Table 3. Key Players of Surgery

Table 4. Key Players of Hematopoietic Stem Cell Transplantation (HSCT)

Table 5. Key Players of Other

Table 6. Global Myasthenia Gravis Disease Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 7. Global Myasthenia Gravis Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Myasthenia Gravis Disease Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global Myasthenia Gravis Disease Market Share by Region (2018-2023)

Table 10. Global Myasthenia Gravis Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global Myasthenia Gravis Disease Market Share by Region (2024-2029)

Table 12. Myasthenia Gravis Disease Market Trends

Table 13. Myasthenia Gravis Disease Market Drivers

Table 14. Myasthenia Gravis Disease Market Challenges

Table 15. Myasthenia Gravis Disease Market Restraints

Table 16. Global Myasthenia Gravis Disease Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global Myasthenia Gravis Disease Revenue Share by Players (2018-2023)

Table 18. Global Top Myasthenia Gravis Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Disease as of 2022)

Table 19. Global Myasthenia Gravis Disease Industry Ranking 2021 VS 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Myasthenia Gravis Disease Revenue (CR5 and HHI) & (2018-2023)

Table 21. Global Key Players of Myasthenia Gravis Disease, Headquarters and Area Served

Table 22. Global Key Players of Myasthenia Gravis Disease, Product and Application

Table 23. Global Key Players of Myasthenia Gravis Disease, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Myasthenia Gravis Disease Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global Myasthenia Gravis Disease Revenue Market Share by Type (2018-2023)

Table 27. Global Myasthenia Gravis Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global Myasthenia Gravis Disease Revenue Market Share by Type (2024-2029)

Table 29. Global Myasthenia Gravis Disease Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global Myasthenia Gravis Disease Revenue Share by Application (2018-2023)

Table 31. Global Myasthenia Gravis Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global Myasthenia Gravis Disease Revenue Share by Application (2024-2029)

Table 33. North America Myasthenia Gravis Disease Market Size by Type (2018-2023) & (US$ Million)

Table 34. North America Myasthenia Gravis Disease Market Size by Type (2024-2029) & (US$ Million)

Table 35. North America Myasthenia Gravis Disease Market Size by Application (2018-2023) & (US$ Million)

Table 36. North America Myasthenia Gravis Disease Market Size by Application (2024-2029) & (US$ Million)

Table 37. North America Myasthenia Gravis Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. North America Myasthenia Gravis Disease Market Size by Country (2018-2023) & (US$ Million)

Table 39. North America Myasthenia Gravis Disease Market Size by Country (2024-2029) & (US$ Million)

Table 40. Europe Myasthenia Gravis Disease Market Size by Type (2018-2023) & (US$ Million)

Table 41. Europe Myasthenia Gravis Disease Market Size by Type (2024-2029) & (US$ Million)

Table 42. Europe Myasthenia Gravis Disease Market Size by Application (2018-2023) & (US$ Million)

Table 43. Europe Myasthenia Gravis Disease Market Size by Application (2024-2029) & (US$ Million)

Table 44. Europe Myasthenia Gravis Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Europe Myasthenia Gravis Disease Market Size by Country (2018-2023) & (US$ Million)

Table 46. Europe Myasthenia Gravis Disease Market Size by Country (2024-2029) & (US$ Million)

Table 47. China Myasthenia Gravis Disease Market Size by Type (2018-2023) & (US$ Million)

Table 48. China Myasthenia Gravis Disease Market Size by Type (2024-2029) & (US$ Million)

Table 49. China Myasthenia Gravis Disease Market Size by Application (2018-2023) & (US$ Million)

Table 50. China Myasthenia Gravis Disease Market Size by Application (2024-2029) & (US$ Million)

Table 51. Asia Myasthenia Gravis Disease Market Size by Type (2018-2023) & (US$ Million)

Table 52. Asia Myasthenia Gravis Disease Market Size by Type (2024-2029) & (US$ Million)

Table 53. Asia Myasthenia Gravis Disease Market Size by Application (2018-2023) & (US$ Million)

Table 54. Asia Myasthenia Gravis Disease Market Size by Application (2024-2029) & (US$ Million)

Table 55. Asia Myasthenia Gravis Disease Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 56. Asia Myasthenia Gravis Disease Market Size by Region (2018-2023) & (US$ Million)

Table 57. Asia Myasthenia Gravis Disease Market Size by Region (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Type (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Type (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Application (2018-2023) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Application (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Myasthenia Gravis Disease Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 63. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Country (2018-2023) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size by Country (2024-2029) & (US$ Million)

Table 65. Bausch Health Company Details

Table 66. Bausch Health Business Overview

Table 67. Bausch Health Myasthenia Gravis Disease Product

Table 68. Bausch Health Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 69. Bausch Health Recent Developments

Table 70. Sun Pharmaceuticals Industries Company Details

Table 71. Sun Pharmaceuticals Industries Business Overview

Table 72. Sun Pharmaceuticals Industries Myasthenia Gravis Disease Product

Table 73. Sun Pharmaceuticals Industries Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 74. Sun Pharmaceuticals Industries Recent Developments

Table 75. Novartis Pharmaceuticals Company Details

Table 76. Novartis Pharmaceuticals Business Overview

Table 77. Novartis Pharmaceuticals Myasthenia Gravis Disease Product

Table 78. Novartis Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 79. Novartis Pharmaceuticals Recent Developments

Table 80. Teva Pharmaceutical Industries Company Details

Table 81. Teva Pharmaceutical Industries Business Overview

Table 82. Teva Pharmaceutical Industries Myasthenia Gravis Disease Product

Table 83. Teva Pharmaceutical Industries Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 84. Teva Pharmaceutical Industries Recent Developments

Table 85. Cipla Company Details

Table 86. Cipla Business Overview

Table 87. Cipla Myasthenia Gravis Disease Product

Table 88. Cipla Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 89. Cipla Recent Developments

Table 90. Roche Company Details

Table 91. Roche Business Overview

Table 92. Roche Myasthenia Gravis Disease Product

Table 93. Roche Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 94. Roche Recent Developments

Table 95. Apotex Corporation Company Details

Table 96. Apotex Corporation Business Overview

Table 97. Apotex Corporation Myasthenia Gravis Disease Product

Table 98. Apotex Corporation Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 99. Apotex Corporation Recent Developments

Table 100. Pfizer Company Details

Table 101. Pfizer Business Overview

Table 102. Pfizer Myasthenia Gravis Disease Product

Table 103. Pfizer Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 104. Pfizer Recent Developments

Table 105. Bristol-Myers And Company Company Details

Table 106. Bristol-Myers And Company Business Overview

Table 107. Bristol-Myers And Company Myasthenia Gravis Disease Product

Table 108. Bristol-Myers And Company Revenue in Myasthenia Gravis Disease Business (2018-2023) & (US$ Million)

Table 109. Bristol-Myers And Company Recent Developments

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Myasthenia Gravis Disease Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Myasthenia Gravis Disease Market Share by Type: 2022 VS 2029

Figure 3. Medication Features

Figure 4. Surgery Features

Figure 5. Hematopoietic Stem Cell Transplantation (HSCT) Features

Figure 6. Other Features

Figure 7. Global Myasthenia Gravis Disease Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 8. Global Myasthenia Gravis Disease Market Share by Application: 2022 VS 2029

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Academic Research Institutes Case Studies

Figure 12. Myasthenia Gravis Disease Report Years Considered

Figure 13. Global Myasthenia Gravis Disease Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Myasthenia Gravis Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Myasthenia Gravis Disease Market Share by Region: 2022 VS 2029

Figure 16. Global Myasthenia Gravis Disease Market Share by Players in 2022

Figure 17. Global Top Myasthenia Gravis Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Disease as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Myasthenia Gravis Disease Revenue in 2022

Figure 19. North America Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Myasthenia Gravis Disease Market Share by Type (2018-2029)

Figure 21. North America Myasthenia Gravis Disease Market Share by Application (2018-2029)

Figure 22. North America Myasthenia Gravis Disease Market Share by Country (2018-2029)

Figure 23. United States Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Canada Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Myasthenia Gravis Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 26. Europe Myasthenia Gravis Disease Market Share by Type (2018-2029)

Figure 27. Europe Myasthenia Gravis Disease Market Share by Application (2018-2029)

Figure 28. Europe Myasthenia Gravis Disease Market Share by Country (2018-2029)

Figure 29. Germany Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. France Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. U.K. Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Italy Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Russia Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Nordic Countries Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. China Myasthenia Gravis Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 36. China Myasthenia Gravis Disease Market Share by Type (2018-2029)

Figure 37. China Myasthenia Gravis Disease Market Share by Application (2018-2029)

Figure 38. Asia Myasthenia Gravis Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 39. Asia Myasthenia Gravis Disease Market Share by Type (2018-2029)

Figure 40. Asia Myasthenia Gravis Disease Market Share by Application (2018-2029)

Figure 41. Asia Myasthenia Gravis Disease Market Share by Region (2018-2029)

Figure 42. Japan Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. South Korea Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. China Taiwan Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. India Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Australia Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Size YoY (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Share by Type (2018-2029)

Figure 50. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Share by Application (2018-2029)

Figure 51. Middle East, Africa, and Latin America Myasthenia Gravis Disease Market Share by Country (2018-2029)

Figure 52. Brazil Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Mexico Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Turkey Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Israel Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. GCC Countries Myasthenia Gravis Disease Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Bausch Health Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 59. Sun Pharmaceuticals Industries Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 60. Novartis Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 61. Teva Pharmaceutical Industries Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 62. Cipla Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 63. Roche Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 64. Apotex Corporation Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 65. Pfizer Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 66. Bristol-Myers And Company Revenue Growth Rate in Myasthenia Gravis Disease Business (2018-2023)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Virtual Clinical Trials Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31U5591

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

Global Clinical Data Management and Statistical Analysis Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E10402

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Global Cancer Tumor Profiling Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6B2891

Tue Apr 02 00:00:00 UTC 2024

Add to Cart

Global Cord Blood Stem Cell Storage Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21T16834

Tue Apr 02 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions